Tuesday, October 19, 2021

Mid-Day Market Replace: Silver Surges 3%; Galera Therapeutics Shares Plunge

Halfway via buying and selling Tuesday, the Dow traded up 0.47% to 35,423.05 whereas the NASDAQ rose 0.59% to fifteen,110.79….

By Staff , in Silver , at October 19, 2021

Halfway via buying and selling Tuesday, the Dow traded up 0.47% to 35,423.05 whereas the NASDAQ rose 0.59% to fifteen,110.79. The S&P additionally rose, gaining 0.61% to 4,513.69.

The U.S. has the very best variety of coronavirus circumstances and deaths on the earth, reporting a complete of 45,908,210 circumstances with round 746,500 deaths. India confirmed a complete of no less than 34,094,370 circumstances and 452,480 deaths, whereas Brazil reported over 21,651,910 COVID-19 circumstances with 603,520 deaths. In whole, there have been no less than 242,021,450 circumstances of COVID-19 worldwide with greater than 4,923,690 deaths, based on information compiled by Johns Hopkins College.

Main and Lagging Sectors

Well being care shares gained by 1.5% on Tuesday. In the meantime, high gainers within the sector included HCW Biologics Inc. (NASDAQ: HCWB), up 20% and Concord Biosciences Holdings, Inc. (NASDAQ: HRMY) up 15%.

In buying and selling on Tuesday, client staples shares fell 0.6%.

High Headline

Johnson & Johnson (NYSE: JNJ) reported better-than-expected earnings for its third quarter and raised its FY21 forecast.

Johnson & Johnson reported quarterly earnings of $2.60 per share, beating analysts’ estimates of $2.36 per share. The corporate reported quarterly income of $23.34 billion, versus analysts’ estimates of $23.74 billion.

Johnson & Johnson raised FY21 steering to total gross sales of $94.1 billion – $94.6 billion ($93.8 billion – $94.6 billion beforehand), together with $2.5 billion from COVID-19 vaccine gross sales. It expects adjusted EPS of $9.77-$9.82, as towards the sooner outlook of $9.60 – $9.70, greater than the consensus of $9.66.

Equities Buying and selling UP

HCW Biologics Inc. (NASDAQ: HCWB) shares shot up 20% to $3.40.

Shares of Concord Biosciences Holdings, Inc. (NASDAQ: HRMY) bought a lift, capturing 15% to $43.93 after it was introduced the corporate will substitute Retail Properties of America within the S&P SmallCap 600.

InflaRx N.V. (NASDAQ: IFRX) shares have been additionally up, gaining 11% to $2.6913 after the corporate introduced it was awarded an as much as roughly $50.7 million grant by the German authorities to advance the event of vilobelimab for the remedy of extreme COVID-19.

Take a look at these massive movers of the day

Equities Buying and selling DOWN

Galera Therapeutics, Inc. (NASDAQ: GRTX) shares tumbled 68% to $2.34 in response to disappointing information from the Section 3 ROMAN trial of avasopasem manganese in extreme oral mucositis (SOM) sufferers with domestically superior head and neck most cancers (HNC) present process standard-of-care radiotherapy.

Shares of Atea Prescribed drugs, Inc. (NASDAQ: AVIR) have been down 62% to $15.35 after the corporate reported information from the Section 2 MOONSONG trial of AT-527 within the outpatient setting in sufferers with gentle or reasonable COVID-19. The trial didn’t meet the first endpoint of clear discount in SARS-CoV-2 viral load within the total inhabitants in comparison with placebo.

EverQuote, Inc. (NASDAQ: EVER) was down, falling 15% to $14.81 after the corporate reduce third-quarter gross sales steering under estimates.


In commodity information, oil traded up 0.9% to $83.15, whereas gold traded up 0.3% to $1,771.70.

Silver traded up 3% Tuesday to $23.96 whereas copper fell 0.3% to $4.7135.

Euro zone

European shares have been principally greater as we speak. The eurozone’s STOXX 600 gained 0.36%, the Spanish Ibex Index rose 0.63% and the German DAX 30 gained 0.33%. In the meantime, the London’s FTSE 100 rose 0.22%, French CAC 40 slipped 0.05% and Italy’s FTSE MIB gained 0.43%.

Spanish commerce deficit widened to EUR 3.87 billion in August from a EUR 1.73 billion hole within the year-ago month.


Housing begins dropped by 1.6% to an annual fee of 1.555 million in September, whereas constructing permits fell 7.7% to an annual fee of 1.589 million.

Federal Reserve Financial institution of Atlanta President Raphael Bostic is ready to talk at 1:00 p.m. ET.

Take a look at the complete financial calendar right here

© 2021 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.

Source link